Brief Review of Nuclear Pharmaceutical Study at IHIP

Wagn Xiang-yun

doi:10.11804/NuclPhysRev.13.02.060

Wagn Xiang-yun. Brief Review of Nuclear Pharmaceutical Study at IHIP[J]. Nuclear Physics Review, 1996, 13(2): 60-61. DOI: 10.11804/NuclPhysRev.13.02.060

Citation:

Wagn Xiang-yun. Brief Review of Nuclear Pharmaceutical Study at IHIP[J]. Nuclear Physics Review, 1996, 13(2): 60-61. DOI: 10.11804/NuclPhysRev.13.02.060

Citation:

Wagn Xiang-yun. Brief Review of Nuclear Pharmaceutical Study at IHIP[J]. Nuclear Physics Review, 1996, 13(2): 60-61. DOI: 10.11804/NuclPhysRev.13.02.060

Brief Review of Nuclear Pharmaceutical Study at IHIP

Wagn Xiang-yun

Graphical Abstract

Graphical Abstract

Abstract

Abstract

The labeling of anti tumor monoclonalantibodies (McAB) with radionuclides has been regarded as our main aim in the past 12 years. A procedure of preparation of ultrapure carrier free 111 In has been developed. Anti tumor McABs labeled with 111 In via a bifunctional conjugating agent (DTPA cycloanhydride) were used successfully in clinical trials. 99m Tc labeled McAB fragments prepared by a direct method were also proved very powerful in diagnosis of gastric carcinoma...

FullText(HTML)

References (0)

Cited By

Brief Review of Nuclear Pharmaceutical Study at IHIP

Graphical Abstract

Abstract

Catalog

Export File

Citation

Format

Content